PROTEAS BIOANALYTICS INC.
Blood test measuring plasma and cell proteomic signatures to assess coronary vascular function and coronary artery disease risk
- Sector
- Medtech
- Headquarters
- Torrance, CA
- Founded
- 2020
- Latest Form D
- $365K, Mar 2023
- Total capital
- $1M
- Federal grants
- $295K
- 1 award · 2022
- Rank in peer group#13 of 68
- Private capital raised
- $730K
- 2 Form D · last Mar 2023
- 43 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 3 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$365K
- Federal grantHealth and Human S · Phase I · Addressing The Continuing Challenge Of Identifying And Managing Coronary Risk: A Person-specific Strategy Using Proteomics$295K
- Private capital raisedForm D · SEC · 1st filing$365K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 68 peers
Line = medianMedtech · Instrument
- Federal grants#13 · top 19%
- Linked publications#2 · top 3%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Spiros GarbisResearcherExecutive Officer, DirectorLinked by $295K in grants as PI
- Antigoni ManousopoulouDirectorNamed in SEC Form D filings
- Dimitrios D. IliopoulosDirectorNamed in SEC Form D filings
- Keith B. HoffmanDirectorNamed in SEC Form D filings
- Valerie DarlingDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 3- PendingMass Spectrometry Sample Processing Methods, Chromatography Devices, And Data Analysis Techniques For Biomarker AnalysisUSPTOApplication 18267411
- PendingMass Spectrometry Sample Processing Methods, Chromatography Devices, And Data Analysis Techniques For Biomarker AnalysisUSPTOApplication PCTUS2021063407
- PendingMass Spectrometry Sample Processing Methods, Chromatography Devices, And Data Analysis Techniques For Biomarker AnalysisUSPTOApplication 63125955
Recent research by its founders
- Functional analysis of O-GlcNAcylation by networking of OGT interactors and substrates20263 cites
- Disruption of the SYNGAP1 PDZ ligand motif accelerates differentiation of human iPSC-derived GABAergic neurons20262 cites
- Novel Plasma Proteomics and Phosphoproteomics Platform Captures Pleiotropic Cardiometabolic Spectrum Effects of Semaglutide in Patients with T2D and Atherosclerosis: A Companion Diagnostic Pilot Study from the STOP (Semaglutide Treatment On coronary atherosclerosis Progression) Randomized Trial20260 cites
Related companies, and why
- CONTRALINE, INC.Similar federal contract value in Medtech · null in contracts
- FAUXSEE INNOVATIONS LLCSimilar federal contract value in Medtech · null in contracts
- CELL IDX, INC.Similar federal contract value in Medtech · null in contracts
- GATEWAY BIOTECHNOLOGY, INC.Similar federal contract value in Medtech · null in contracts
- MicroStructure Imaging, Inc.Similar federal contract value in Medtech · null in contracts
- ENDOTHEIA INCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .